Ai-Min Hui

Takeda (United States) — United States

Medicine · Health Sciences

16h-index3.7kcitations17works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(6), Ubiquitin and proteasome pathways(6), Protein Degradation and Inhibitors(5), Epigenetics and DNA Methylation(4), Peptidase Inhibition and Analysis(3)

Publications17 total

A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis
Blood·2017· 122 citedOpen Access
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
New England Journal of Medicine·2016· 1.0k citedOpen Access
The Investigational Proteasome Inhibitor Ixazomib for the Treatment of Multiple Myeloma
Future Oncology·2015· 26 cited
Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignancies
Investigational New Drugs·2015· 42 citedOpen Access
Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study
The Lancet Oncology·2014· 261 cited
Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients
Blood·2014· 200 citedOpen Access
Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma
Blood·2014· 192 citedOpen Access
Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain
Cancer Cell·2006· 881 citedOpen Access
Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas
International Journal of Oncology·2005· 50 cited
Agents with Selective Estrogen Receptor (ER) Modulator Activity Induce Apoptosis<b><i>In vitro</i></b>and<b><i>In vivo</i></b>in ER-Negative Glioma Cells
Cancer Research·2004· 73 cited
Proliferative marker Ki-67 in gallbladder carcinomas: high expression level predicts early recurrence after surgical resection
Cancer Letters·2002· 23 cited
An Obstructed Venous Aneurysm Presenting as an Abdominal Mass: Report of a Case
Surgery Today·2001· 5 cited
Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy
Hepatology·1999· 319 cited
Reduced p27Kip1 expression in hepatocellular carcinomas
Cancer Letters·1998· 36 cited
DNA hypermethylation at the D17S5 locus is associated with gastric carcinogenesis
Cancer Letters·1998· 57 cited
The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas
International Journal of Cancer·1997· 253 cited
Liver Injury Following Normothermic Ischemia in Steatotic Rat Liver
Hepatology·1994· 100 cited

Frequent Co-authors

Deborah Berg(6), Neeraj Gupta(6), Alessandra Di Bacco(5), Shaji Kumar(4), Jacob P. Laubach(4), Paul G. Richardson(4), Tadatoshi Takayama(3), Masatoshi Makuuchi(3), Yae Kanai(3), Setsuo Hirohashi(3), Philippe Moreau(2), Jianchang Lin(2), Howard A. Fine(2), Guido Torzilli(2), Rubén Niesvizky(2), Sagar Lonial(2), Saori Ushijima(2), Atsushi Ochiai(2), Michiie Sakamoto(2), Guohui Liu(2)